Article
Melanoma causes phenotypic modulations and metabolic switches of iNKT cells influencing clinical outcomes.
Frontiers in immunology - 1 Jan 2025
Degeorges Emmanuelle, Mouret Stéphane, Girard Pauline, Niveau Camille, Cettour-Cave Mélanie, Sosa Cuevas Eleonora, De Fraipont Florence, Charles Julie, Saas Philippe, Aspord Caroline
Abstract excerpt
Introduction: Invariant NKT (iNKT) cells are crucial effectors in cancer immunosurveillance, due to their immunomodulatory potential through a broad range of effector and regulatory functions. Yet, their use as targets or vectors for cancer immunotherapy in cancer yielded inconsistent outcomes, due to potential tumor immune escape mechanisms. Limited information is available regarding the potential dysfunctions...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
